DNA VECTOR GDTT1.8NAS12-HIF1α TO INCREASE THE EXPRESSION LEVEL OF THE TARGET HIF1α GENE AND APPLICATION METHOD Russian patent published in 2023 - IPC C07K14/515 C12N15/66 C12N15/85 A61K48/00 A61P9/00 

Abstract RU 2793809 C1

FIELD: biotechnology.

SUBSTANCE: invention relates to the field of biotechnology, specifically to the production of genetically engineered therapeutic drugs, and can be used in medicine to increase the expression level of the target HIF1α gene in humans and animals. A 5057 p.n. GDTT1.8NAS12-HIF1α DNA vector was constructed with the nucleotide sequence of SEQ ID NO: 4 and the general structure shown in FIG. 1D.

EFFECT: invention ensures achievement of a therapeutic effect by introducing a gene therapeutic DNA vector with a target HIF1α gene into cells of an animal and human body characterized by reduced or insufficient expression of the protein encoded by this gene.

3 cl, 15 dwg, 20 ex

Similar patents RU2793809C1

Title Year Author Number
DNA VECTOR GDTT1.8NAS12-ANG FOR INCREASING LEVEL OF EXPRESSION OF TARGET GENE ANG IN HUMAN AND ANIMAL ORGANISM, ITS APPLICATION METHOD 2019
  • Gamolski Anton
RU2774352C2
DNA VECTOR GDTT1.8NAS12-ANGPT1 TO INCREASE THE EXPRESSION LEVEL OF THE TARGET ANGPT1 GENE, THE METHOD FOR ITS PREPARATION AND APPLICATION 2022
  • Gamolski Anton
RU2793971C1
GDTT1.8NAS12-VEGFA DNA VECTOR FOR INCREASING THE EXPRESSION LEVEL OF THE TARGET VEGFA GENE, METHOD FOR ITS PREPARATION AND APPLICATION 2022
  • Gamolski Anton
RU2794133C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES ANG, ANGPT1, VEGFA, FGF1, HIF1Α, HGF, SDF1, KLK4, PDGFC, PROK1, PROK2 TO INCREASE EXPRESSION LEVEL OF SAID TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-ANG, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-ANGPT1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-VEGFA, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-FGF1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HIF1Α, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HGF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SDF1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-KLK4, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PDGFC, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PROK1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PROK2, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2730664C2
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR GDTT1_8NAS12, CARRYING TARGET GENE SELECTED FROM GROUP OF IFNB1, IFNA14, IFNA2, IL12A, IL12B GENES TO INCREASE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IFNB1, OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IFNA14, OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IFNA2, OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL12A, OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL12B, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2019
  • Gamolski Anton
RU2741570C1
GENE-THERAPEUTIC DNA VECTOR BASED ON THE GENE-THERAPEUTIC DNA VECTOR GDTT1_8NAS12, CARRYING THE TARGET GENE SELECTED FROM A GROUP OF GENES DDC, IL10, IL13, IFNB1, TNFRSF4, TNFSF10, BCL2, HGF, IL2 TO INCREASE THE EXPRESSION LEVEL OF SAID TARGET GENES, A METHOD FOR PRODUCTION AND USE THEREOF, A STRAIN ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-DDC OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL10 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL13 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IFNB1 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-TNFRSF4 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-TNFSF10 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-BCL2 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-HGF OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL2, CARRYING A GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR 2020
  • Gamolski Anton
RU2734726C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR GDTT1_8NAS12, CARRYING TARGET HFE GENE TO INCREASE EXPRESSION LEVEL OF THIS TARGET GENE, METHOD FOR PRODUCTION AND USE THEREOF, ESCHERICHIA COLI STRAIN JM110-NAS/GDTT1_8NAS12-HFE CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2019
  • Gamolski Anton
RU2733429C1
GENE-THERAPEUTIC DNA-VECTOR GDTT1.8NAS12, METHOD FOR ITS PREPARATION, ESCHERICHIA COLI JM110-NAS STRAIN, A METHOD FOR ITS PREPARATION, ESCHERICHIA COLI JM110-NAS/GDTT1.8NAS12 STRAIN, CARRYING A GENE-THERAPEUTIC DNA-VECTOR GDTT1.8NAS12, A METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR 2018
  • Gamolski Anton
RU2712838C1
DNA VACCINE AGAINST SARS-COV-2 VIRUS BASED ON GENE THERAPY DNA VECTOR GDTT1.8NAS12, METHOD FOR ITS PREPARATION, STRAINS CARRYING GENE-THERAPY DNA VECTORS, METHOD FOR THEIR PREPARATION, METHOD FOR PRODUCTION ON INDUSTRIAL SCALE OF GENE-THERAPY DNA VECTORS 2020
  • Gamolski Anton
RU2759227C2
GENE-THERAPEUTIC DNA VECTOR FOR TARGETED GENE THERAPY, METHOD FOR PRODUCTION THEREOF (EMBODIMENTS), STRAIN FOR PRODUCTION THEREOF, METHOD FOR PRODUCTION THEREOF 2018
  • Gamolski Anton
RU2714763C1

RU 2 793 809 C1

Authors

Gamolski Anton

Dates

2023-04-06Published

2022-02-03Filed